Cambrian BioPharma Inc — Form D
Cambrian BioPharma Inc of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2021-05-06. The offering totals $28.4M, of which $28.4M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-05-06
- Form: D
- Accession: 0000897069-21-000216
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $28.4M
- Amount sold: $28.4M
- Investors: 30
- Date of first sale: 2020-10-20
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-398458
Issuer
- Name: Cambrian BioPharma Inc
- CIK: 0001797409
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 228 Park Avenue South Suite 66643, NEW YORK, NY, 10003
- Phone: (516) 962-3186
Officers, directors & promoters (19)
| Name | Role | Location |
|---|
| Christian G Angermeyer | Director | New York, NY |
| Maryanna Saenko | Related Person | Los Altos, CA |
| James Peyer | Related Person | New York, NY |
| Juliette Han | Related Person | New York, NY |
| Christian G Angermayer | Director | New York, NY |
| Maryanna G Saenko | Director | New York, NY |
| Paul G Farr | Director | New York, NY |
| James G Peyer | Director | New York, NY |
| James G Peyer | Executive Officer | New York, NY |
| James G Peyer | Promoter | New York, NY |
| Brenton G Saunders | Director | New York, NY |
| Paul Farr | Related Person | Santa Monica, CA |
| Mark Nuttall | Related Person | New York, NY |
| Ruth Thieroff-Ekerdt | Related Person | New York, NY |
| William DeVaul | Related Person | New York, NY |
| Christian Angermeyer | Related Person | Birkirkara, O1 |
| Brenton L. Saunders | Related Person | Bridgewater, NJ |
| Martin Gunhaga | Related Person | Umea, V7 |
| Lorin Van Nuland | Related Person | Birkirkara, O1 |
Other filings by this issuer (5)
More